Russia rushes its vaccine
Russia has dashed across the finish line and seized the trophy for being the first nation to release a vaccine for Covid-19. It has been nicknamed “Sputnik 5”, recalling the Soviet Union’s glorious triumphs in the Space Race of the 1950s and 60s.
Scientists and bioethicists around the world, and even in Russia, have grave misgivings. Sputnik 5 has not even completed Phase 3 clinical trials. If the Russian vaccine is ineffective or unsafe, it could deter many people from being inoculated with an effective vaccine when it arrives.
By one of those awful coincidences which sometimes happen with new products, Sputnik 5 is being trialled at the same time as a Russian movie which is also called “Sputnik”. This, however, is a horror film about a guest which returns from outer space with an unlucky cosmonaut. It turns out to be a slithering extraterrestrial parasite which feasts on human brains. (Rated 90% on Rotten Tomatoes).
Is there a translation for Murphy’s Law?
Sputnik 5 has not gone through Phase 3 trials
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...